Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Aradigm  (Stock symbol: ARDM )

3929 Point Eden Way
Hayward, CA 94545
Website Company Summary Management Team

Management: Nancy Pecota (CFO) Theresa Sevilla (Manager, Benefits & HR Administration)
Outside board: Virgil Thompson (Spinnaker Biosciences CEO);  John M. Siebert (CyDex CEO/Chairman)David Bell (Grifols);  Lafmin Morgan (Grifols President, Marketing);  Frederick M. Hudson (KPMG Former Partner)
Advisory board: Peter Byron (Virginia Commonwealth University Professor of Pharmacology);  Henrik Egesborg Hansen (Novo Nordisk Division VP);  Peter Creticos (Johns Hopkins School of Medicine Associate Professor);  Robert Ratner (MedStar Research Institute)

Business description: Aradigm is an emerging specialty pharmaceutical company developing and commercializing a portfolio of drugs delivered by inhalation for the treatment of severe respiratory disease.bbBolstered by its depth of expertise in pulmonary drug delivery and an extensive intellectual property portfolio, the Company is uniquely positioned to fulfill unmet needs in pulmonary medicine. Our corporate strategy includes the following: • Continued development of proprietary respiratory disease therapies • Pursue regulatory pathways that reduce the time, costs and risks associated with product development • Conservation of capital for proprietary product development through the outsourcing of late stage clinical and commercial scale manufacturing • Deployment of a specialized sales and marketing force to meet the unique needs of pulmonologists in the United States • Out-licensing technology and intellectual property assets for applications that lie outside the company's strategic interests and core expertise
Partners include: APT Pharmaceuticals;  CyDex;  Lung Rx ;  Novo Nordisk

Rounds: 3
Recent fundings: Feb 2003   Dec 2001
Capital raised: 105.0M
Ownership: Public  
Stock Symbol: ARDM
VCs include: Brentwood Venture CapitalSequoia CapitalSprout GroupVersant Ventures;  Electronic Investment
Corporate investors: GE CapitalTVI

Last Tweets


Last Mentions

Record updated: Apr 2015
Sector: Medical
Year Founded: 1991
Rounds: 3
Recent fundings: Feb 2003   Dec 2001
Capital raised: 105.0M
Ownership: Public  
Stock Symbol: ARDM